Kanavakis E, Traeger-Synodinos J, Papasotiriou I, Vrettou C, Metaxotou-Mavromati A, Stamoulakatou A, Lagona E, Kattamis C
First Department of Paediatrics, University of Athens, St Sophia's Children's Hospital, Greece.
Br J Haematol. 1996 Feb;92(2):332-5. doi: 10.1046/j.1365-2141.1996.d01-1487.x.
The clinical, haematological, biosynthetic and molecular data of three Greek haemoglobin H (HbH) disease patients with a distinctive clinical phenotype are described. During infancy all three patients had unusually severe clinical manifestations for HbH disease, with anaemia necessitating blood transfusions, signs of bone changes, growth impairment, and splenomegaly. Molecular analysis identified a rare alpha-thalassaemia genotype (--Med/ alpha Ic alpha). Splenectomy resulted in marked amelioration of the clinical signs; post splenectomy all three patients preserve adequate haemoglobin levels (9-10 g/dl) with growth restored to normal. Despite the initial severe clinical phenotype in these patients, our experience indicates that splenectomy modifies the clinical course to that of mild thalassaemia intermedia. This observation should be considered carefully when giving genetic counselling to families carrying the rare Hb Icaria mutation and an alpha zero thalassaemia mutation.
本文描述了三名具有独特临床表型的希腊血红蛋白H(HbH)病患者的临床、血液学、生物合成及分子数据。在婴儿期,所有三名患者的HbH病临床表现异常严重,出现贫血需输血、骨骼改变体征、生长发育迟缓及脾肿大。分子分析确定了一种罕见的α地中海贫血基因型(--Med/αIcα)。脾切除术后临床症状明显改善;脾切除术后所有三名患者血红蛋白水平维持在适当水平(9 - 10g/dl),生长恢复正常。尽管这些患者最初临床表现严重,但我们的经验表明,脾切除术可将临床病程改变为轻度中间型地中海贫血。在为携带罕见的Hb Icaria突变和α0地中海贫血突变的家庭提供遗传咨询时,应仔细考虑这一观察结果。